24 February 2024 : Clinical Research
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study
Yaodong Li1AEF, Yangxin Chen2BCD, Jingfeng Wang2BCD, Jian Xu3BCD, Ruogu Li4BCD, Zhaohui Qiu5BCD, Lingyun Jiang6BCD, Farong Shen7BCD, Shubin Jiang8BCD, Bin Li9BCD, Yingjie Chu10BCD, Lang He11BCD, Lijin Pu12BCD, Xuebin Han13BCD, Xianping Long14BCD, Xiaolin Xue15BCD, Jianhong Tao16BCD, Yongquan Wu17BCD, Tao Guo18BCD, Yiqiang Yuan19BCD, Xianqing Wang20BCD, Jiang Wang21BCD, Jing Xu22BCD, Yujie Zhao23BCD, Zhihui Zhang24BCD, Wei Hua25ABCD*, Yangang Su26ABCD, Baopeng Tang27ABCDEFGDOI: 10.12659/MSM.942747
Med Sci Monit 2024; 30:e942747
Table 2 Primary endpoint and secondary endpoints.






